The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partner Company Update

1 May 2012 07:00

RNS Number : 4213C
Amphion Innovations PLC
01 May 2012
 



 

 

 

Amphion Partner Company, AXCESS, Receives Markman ruling in Savi Litigation

 

 

London and New York, 1 May 2012 - Amphion Innovations plc (LSE: AMP), announces that a Markman ruling was issued in case no. 3:10-cv-01033-F, Axcess International, Inc. (Axcess) vs. Savi Technology, Inc. (Savi) in the United States District Court for the Northern District of Texas, Dallas Division. Also announced is the trial date, now set for November 5, 2012.

 

Amphion Partner Company, Axcess International was issued a patent on September 25, 2001 entitled "High Sensitivity Demodulator for a Radio Tag and Method". The patent discloses a radio tag that uses circuitry capable of demodulating low powered analog carrier signals while drawing minimal current to improve the sensitivity and operational range of the radio tag while maintaining longer battery life. Axcess filed suit against Savi on May 21, 2010 accusing Savi's RFID tags of infringing 23 claims of the patent.

 

A "Markman" hearing is a pretrial hearing in a U.S. District Court during which a judge examines evidence from all parties on the appropriate meanings of relevant key words used in a patent claim, when patent infringement is alleged. Holding a Markman hearing in patent infringement cases has been common practice since the case of Markman v. Westview Instruments, Inc.. It was determined the language of a patent is a matter of law for a judge to decide, not a matter of fact for a jury to decide. Markman hearings are important, since the court determines patent infringement cases by the interpretation of claims.

 

Included in the Order were nine disputed and nine agreed-to claims. The Court construed each of the nine disputed claims in the ruling. The Court also resolved one of the parties' fundamental disputes about the scope of the patent. The Court said that the novelty of the invention was a new and improved tag to receive, process, evaluate, and respond to much weaker signals than such tags were capable of doing before, also increasing the operable life span of the radio tag as well as the distance over which the tag can operate.

 

"Having reached this important milestone, we now look forward to the trial in early November. We encourage interested parties to read the Order", said Allan Griebenow, President & CEO of Axcess International. "Axcess remains fully committed to the protection of this patent and others in our intellectual property portfolio."

 

While Amphion believes the above described ruling can be favorable to Axcess the ruling does not automatically mean that Axcess will prevail at trial. A copy of the Court's ruling can be downloaded from the Company's website at www.axcessinc.com.

 

As a result of additional investment in support of Axcess over the last few years, Amphion Innovations' holdings of equity and warrants now amount to about 14% of the fully diluted outstanding. In addition, Amphion holds approximately $1.8 million of debt, most of which is convertible into common stock.

 

 

 

 

For further information please contact:

 

Amphion Innovations

Charlie Morgan:

+1 (212) 210-6224

 

Cardew Group

Tim Robertson

+44 020 7930 0777

 

Seymour Pierce Limited, Nominated Adviser

Mark Percy/ Freddy Crossley:

+44 020 7107 8300

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has a significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

 

On the web: www.amphionplc.com

 

 

About Axcess International Inc.

Axcess International Inc. (OTCBB: AXSI) provides automated wireless identification solutions for business encompassing local location identification, tracking and control capabilities using its patented MicroWirelessTM technology platform. The complete system solutions supersede existing manual ID systems by automating various tasks that increase productivity, security, safety and business intelligence. MicroWireless - based on active RFID principles - is the economic and technological sweet spot for autonomously-powered low cost, miniature, remote wireless communication devices. Axcess is a portfolio company of Amphion Innovations plc (AIM: AMP). For more information on Axcess, visit www.axcessinc.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAURUWRUKASOAR
Date   Source Headline
23rd Dec 20097:01 amRNSFunding & IP Licensing Updates
25th Nov 20097:00 amRNSAmphion Partnership with Kuwait University
30th Oct 20095:11 pmRNSTotal Voting Rights
16th Oct 20092:37 pmRNSDirector/PDMR Shareholding
6th Oct 20098:59 amRNSPartner Company Wellgen Release
21st Sep 20092:41 pmRNSDirector/PDMR Shareholding
20th Aug 20097:00 amRNSHalf Yearly Report
25th Jun 20097:00 amRNSIP License Agreements
4th Jun 20097:00 amRNSAGM Statement
14th May 20095:26 pmRNSAnnual Financial Report
13th May 20095:29 pmRNSIssue of Equity
5th May 20097:00 amRNSIP License Agreements
1st May 20097:00 amRNSDirectorate Change
30th Apr 20095:05 pmRNSTotal Voting Rights
7th Apr 20093:54 pmRNSDirector/PDMR Shareholding
26th Mar 20093:47 pmRNSDirector/PDMR Shareholding
16th Mar 20097:00 amRNSFinal Results
4th Mar 200910:51 amRNSNotice of Results
27th Feb 20094:46 pmRNSDirector Dealings
27th Feb 20091:20 pmRNSAmphion Partner AXCESS International Wins Contract
30th Jan 20097:00 amRNSFunding Update
19th Jan 20097:00 amRNSTrading Statement
31st Dec 20087:00 amRNSConvertible Promisory Note Offering
27th Nov 20087:00 amRNSPartner Company Announces IP License Agreement
31st Oct 20083:46 pmRNSTotal Voting Rights
28th Oct 20087:00 amRNSNew CEO for Partner Company
23rd Oct 20087:00 amRNSDirector/PDMR Shareholding
17th Oct 20087:00 amRNSPartner Company Announces IP Licence Agreement
17th Sep 20087:00 amRNSPartner Company - Product Launch
16th Sep 20087:14 amRNSDirector/PDMR Shareholding
18th Aug 20087:00 amRNSInterim Results
1st Aug 20089:00 amRNSNotice of Interim Results
17th Jun 20082:54 pmRNSDirector/PDMR Shareholding
12th Jun 20087:00 amRNSAGM Statement
10th Jun 20087:00 amRNSPartner Company Announces IP
27th May 20087:00 amRNSDSC Fundraising
23rd May 20087:00 amRNSFundraising for Partner Compa
30th Apr 20082:58 pmRNSTotal Voting Rights
8th Apr 20087:00 amRNSPartner Company Fundraising
7th Apr 20083:46 pmRNSFundraising
26th Mar 200812:36 pmRNSDirector/PDMR Shareholding
13th Mar 20087:12 amRNSFinal Results
3rd Mar 20087:01 amRNSPrivateMarkets Fundraising
27th Feb 20088:00 amRNSNotice of Preliminary Results
31st Jan 20084:51 pmRNSTotal Voting Rights
17th Jan 20087:01 amRNSTrading Statement
7th Jan 20087:00 amRNSDirectors Dealings
30th Nov 20074:53 pmRNSTotal Voting Rights
12th Nov 20077:01 amRNSIssue of Equity
5th Nov 20071:59 pmRNSResult of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.